NCT01583582View on ClinicalTrials.gov

Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
HypertensionBlood Pressure
Interventions
DIETARY_SUPPLEMENT

Marealis Refined Peptide Concentrate

1200 mg per os, once a day, 8 weeks

DIETARY_SUPPLEMENT

Marealis Refined Peptide Concentrate

600 mg per os, twice a day, 8 weeks

DIETARY_SUPPLEMENT

Marealis Refined Peptide Concentrate

0 mg per os, daily, 8 weeks

Trial Locations (1)

70210

Oy Foodfiles Ltd, Kuopio

All Listed Sponsors
lead

Marealis AS

INDUSTRY

NCT01583582 - Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp | Biotech Hunter | Biotech Hunter